CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 106 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2019. The put-call ratio across all filers is 1.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $79,000 | -73.5% | 43,890 | +23.5% | 0.03% | -73.6% |
Q2 2020 | $298,000 | +70.3% | 35,530 | +6.2% | 0.11% | +69.2% |
Q1 2020 | $175,000 | +9.4% | 33,440 | +14.3% | 0.06% | +54.8% |
Q4 2019 | $160,000 | +73.9% | 29,260 | +55.6% | 0.04% | +200.0% |
Q3 2019 | $92,000 | – | 18,810 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 3,738,925 | $23,555,000 | 31.22% |
Perceptive Advisors | 1,232,500 | $7,764,000 | 0.39% |
IFP Advisors, Inc | 1,001,025 | $6,306,000 | 0.27% |
WOODSTOCK CORP | 55,489 | $350,000 | 0.07% |
Virtus ETF Advisers LLC | 50,795 | $320,000 | 0.05% |
Dynamic Technology Lab Private Ltd | 31,431 | $198,000 | 0.04% |
Evanson Asset Management, LLC | 20,660 | $130,000 | 0.03% |
Artal Group S.A. | 250,000 | $1,575,000 | 0.03% |
GSA CAPITAL PARTNERS LLP | 58,800 | $370,000 | 0.02% |
Raymond James Financial Services Advisors, Inc. | 426,280 | $2,686,000 | 0.02% |